Evidence map›Paper›PMID 31114765›Full record

ArticleResearch and reports in urology2019

Expression of protease activating receptor-2 (PAR-2) is positively correlated with the recurrence of non-muscle invasive bladder cancer: an immunohistochemical analysis.

Kozue Nakahara, Koji Yamasaki, Takahiro Nagai, Masato Fujii, Takahiro Akioka, Hiroki Takamori, Naoki Terada, Shoichiro Mukai, Yuichiro Sato, Toshiyuki Kamoto

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Research and reports in urology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Kozue NakaharaDepartment of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Koji YamasakiDepartment of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Takahiro NagaiDepartment of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Masato FujiiDepartment of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Takahiro AkiokaDepartment of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Hiroki TakamoriDepartment of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Naoki TeradaDepartment of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Shoichiro MukaiDepartment of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Yuichiro SatoSection of Diagnostic Pathology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Toshiyuki KamotoDepartment of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
University of Miyazaki · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

matriptaseMETNMIBCPAR-2

Identifiers

PMID31114765
PMCPMC6489562
OpenAlexW2940388539

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.